HCA Healthcare stock declines amid market strength
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 12 2024
0mins
Source: NASDAQ.COM
HCA Healthcare's stock has dropped 3.56%, hitting a 20-day low, despite the broader market's gains with the Nasdaq-100 up 1.86% and the S&P 500 up 0.50%.
The decline of HCA Healthcare's stock, which has fallen 21% year-to-date, is attributed to high cost pressures affecting its operations. However, the company's extensive medical network and strong relationships with patients and physicians position it well to benefit from the aging population trend, making it a potentially attractive long-term investment.
Despite the current price drop, HCA Healthcare's fundamentals remain solid, and its strategic positioning in the healthcare market could lead to recovery as it capitalizes on demographic trends.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HCA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HCA
Wall Street analysts forecast HCA stock price to rise
19 Analyst Rating
13 Buy
5 Hold
1 Sell
Moderate Buy
Current: 361.320
Low
420.00
Averages
491.89
High
525.00
Current: 361.320
Low
420.00
Averages
491.89
High
525.00
About HCA
HCA Healthcare, Inc. is a health care services company. The Company provides acute care hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. It operates approximately 190 hospitals comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals and its facilities are in 19 states and the United Kingdom.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Burry Sees Investment Opportunity in HCA Healthcare
- Investment Opportunity Analysis: Burry describes HCA Healthcare as 'one of the best operator-compounders,' asserting that despite the $900 million headwind from the expiration of enhanced Obamacare subsidies, this creates a buying opportunity, indicating his bullish long-term outlook on HCA.
- Market Reaction: HCA's shares rose nearly 1% in Tuesday's pre-market trading, reflecting a positive market response to Burry's views, even as the stock has declined 23% year-to-date.
- Financial Impact: In its Q1 earnings call, HCA estimated a $150 million impact from the lapse of Obamacare subsidies, with projections for fiscal year 2026 ranging from $600 million to $900 million, highlighting the challenges the company faces in adapting to policy changes.
- M&A Potential: Burry praises HCA's strong performance in M&A, suggesting that any negative impact on HCA will hurt its competitors more, thereby creating acquisition opportunities, which underscores its competitive advantage in the industry.
See More
Investment Opportunities in Healthcare Stocks
- Intuitive Surgical Outlook: Despite a 25% drop in share price this year, Intuitive Surgical's financial performance remains robust, with revenue and procedures growing healthily in Q1, indicating its leadership in the robotic-assisted surgery market and long-term growth potential.
- HCA Healthcare's Market Position: HCA Healthcare's stock has declined 21% year-to-date, yet its extensive medical network and strong relationships with patients and physicians position it well to benefit from the aging population trend, making it an attractive investment.
- Abbott Laboratories' Innovation: While Abbott Laboratories' nutrition and diagnostics segments have hindered sales growth, its core medical device unit remains strong, particularly in structural heart products and diabetes care, which are expected to drive long-term growth.
- Dividend King's Appeal: Abbott Laboratories has increased its dividends for 54 consecutive years, earning the title of Dividend King, showcasing its stable income potential and long-term investment value, appealing to income-seeking investors.
See More
Investment Opportunities in the Healthcare Sector
- Market Challenges and Opportunities: Despite a challenging macroeconomic environment, Intuitive Surgical's stock has fallen 25% this year; however, its financial performance remains strong, with revenue and procedures growing healthily in Q1, indicating its leadership in the robotic-assisted surgery market and long-term growth potential.
- Resilience of HCA Healthcare: HCA Healthcare's stock has declined 21% year-to-date due to high cost pressures, yet its extensive medical network across the U.S. and strong relationships with patients and physicians position the company to benefit from long-term trends like an aging population, making it a worthwhile long-term hold.
- Strength of Abbott's Core Business: Although Abbott's nutrition and diagnostics segments have hindered sales growth, its core medical device division remains robust, particularly in structural heart products and diabetes care, which are expected to drive future growth.
- Attractiveness of Dividend King: Abbott has increased its dividends for 54 consecutive years, earning the title of 'Dividend King'; its stable dividend history and innovation capabilities make it a strong investment option for those seeking consistent income over the long term.
See More
HCA Healthcare Acquires The College of Health Care Professions
- Acquisition Agreement: HCA Healthcare has announced its acquisition of The College of Health Care Professions (CHCP), which educates over 8,000 students annually, enhancing HCA's capacity in workforce development and solidifying its market position in healthcare.
- Talent Development Initiative: The 12-week Medical Assistant training program, launched in collaboration with CHCP, has successfully graduated over 100 employees, increasing their career opportunities within HCA's urgent care centers, demonstrating a shared commitment to improving healthcare service quality.
- Commitment to Education Investment: HCA's ongoing investments in education and workforce development, including funding for various programs in Texas and Florida, underscore its dedication to cultivating the next generation of healthcare workers to meet the growing industry demands.
- Longstanding Partnership: The historical collaboration between HCA and CHCP, involving program advisory boards, clinical placements, and career placement, reflects a mutual vision for student success and academic quality, which is expected to further professionalize the healthcare industry.
See More
Heritage Insurance Options Trading Volume Surges
- Surge in Options Volume: Heritage Insurance Holdings Inc (HRTG) saw options trading volume reach 4,396 contracts today, representing approximately 439,600 shares, which is about 82.4% of its average daily trading volume of 533,505 shares over the past month, indicating strong market interest in the stock.
- High-Frequency Trading Insights: Notably, the $30 strike call option expiring on July 17, 2026, has seen 4,072 contracts traded today, equating to approximately 407,200 shares of HRTG, suggesting a significant bullish sentiment among investors regarding future price increases.
- Zoom Options Activity: Concurrently, Zoom Communications Inc (ZM) has also shown active options trading, with a volume of 40,748 contracts today, representing around 4.1 million shares, which accounts for 79.7% of its average daily trading volume of 5.1 million shares over the past month, reflecting ongoing market interest.
- Put Option Trading: Among ZM's options, the $90 strike put option expiring on May 22, 2026, has recorded a trading volume of 3,290 contracts, representing approximately 329,000 shares, highlighting investor concerns regarding potential downside risks in its stock price.
See More
HCA Healthcare Completes $3 Billion Bond Offering
- Bond Offering Size: HCA Healthcare completed a $3 billion public offering of senior unsecured notes through its wholly owned subsidiary, HCA Inc., on April 30, 2026, with three tranches maturing in 2031, 2033, and 2036, and interest rates ranging from 4.7% to 5.3%.
- Enhanced Financial Flexibility: The bond issuance aims to diversify long-term funding sources and improve the company's financial flexibility, with all notes fully guaranteed by the parent company, indicating HCA's commitment to future financial stability.
- Analyst Rating Adjustment: On April 28, 2027, Bernstein lowered its price target for HCA Healthcare from $541 to $503 while maintaining a Market Perform rating, reflecting a cautious outlook on the company's long-term EBITDA forecasts, projecting a 5.1% CAGR.
- Operational Risks and Opportunities: Despite risks from slowing state supplemental payments, reduced insurance coverage, and potential bad debt growth, Bernstein's analyst noted that strong operational execution and well-controlled margins could offset these financial challenges, demonstrating HCA's resilience in the market.
See More
Burry Sees Investment Opportunity in HCA Healthcare
- Investment Opportunity Analysis: Burry describes HCA Healthcare as 'one of the best operator-compounders,' asserting that despite the $900 million headwind from the expiration of enhanced Obamacare subsidies, this creates a buying opportunity, indicating his bullish long-term outlook on HCA.
- Market Reaction: HCA's shares rose nearly 1% in Tuesday's pre-market trading, reflecting a positive market response to Burry's views, even as the stock has declined 23% year-to-date.
- Financial Impact: In its Q1 earnings call, HCA estimated a $150 million impact from the lapse of Obamacare subsidies, with projections for fiscal year 2026 ranging from $600 million to $900 million, highlighting the challenges the company faces in adapting to policy changes.
- M&A Potential: Burry praises HCA's strong performance in M&A, suggesting that any negative impact on HCA will hurt its competitors more, thereby creating acquisition opportunities, which underscores its competitive advantage in the industry.
See More
Investment Opportunities in Healthcare Stocks
- Intuitive Surgical Outlook: Despite a 25% drop in share price this year, Intuitive Surgical's financial performance remains robust, with revenue and procedures growing healthily in Q1, indicating its leadership in the robotic-assisted surgery market and long-term growth potential.
- HCA Healthcare's Market Position: HCA Healthcare's stock has declined 21% year-to-date, yet its extensive medical network and strong relationships with patients and physicians position it well to benefit from the aging population trend, making it an attractive investment.
- Abbott Laboratories' Innovation: While Abbott Laboratories' nutrition and diagnostics segments have hindered sales growth, its core medical device unit remains strong, particularly in structural heart products and diabetes care, which are expected to drive long-term growth.
- Dividend King's Appeal: Abbott Laboratories has increased its dividends for 54 consecutive years, earning the title of Dividend King, showcasing its stable income potential and long-term investment value, appealing to income-seeking investors.
See More
Investment Opportunities in the Healthcare Sector
- Market Challenges and Opportunities: Despite a challenging macroeconomic environment, Intuitive Surgical's stock has fallen 25% this year; however, its financial performance remains strong, with revenue and procedures growing healthily in Q1, indicating its leadership in the robotic-assisted surgery market and long-term growth potential.
- Resilience of HCA Healthcare: HCA Healthcare's stock has declined 21% year-to-date due to high cost pressures, yet its extensive medical network across the U.S. and strong relationships with patients and physicians position the company to benefit from long-term trends like an aging population, making it a worthwhile long-term hold.
- Strength of Abbott's Core Business: Although Abbott's nutrition and diagnostics segments have hindered sales growth, its core medical device division remains robust, particularly in structural heart products and diabetes care, which are expected to drive future growth.
- Attractiveness of Dividend King: Abbott has increased its dividends for 54 consecutive years, earning the title of 'Dividend King'; its stable dividend history and innovation capabilities make it a strong investment option for those seeking consistent income over the long term.
See More
HCA Healthcare Acquires The College of Health Care Professions
- Acquisition Agreement: HCA Healthcare has announced its acquisition of The College of Health Care Professions (CHCP), which educates over 8,000 students annually, enhancing HCA's capacity in workforce development and solidifying its market position in healthcare.
- Talent Development Initiative: The 12-week Medical Assistant training program, launched in collaboration with CHCP, has successfully graduated over 100 employees, increasing their career opportunities within HCA's urgent care centers, demonstrating a shared commitment to improving healthcare service quality.
- Commitment to Education Investment: HCA's ongoing investments in education and workforce development, including funding for various programs in Texas and Florida, underscore its dedication to cultivating the next generation of healthcare workers to meet the growing industry demands.
- Longstanding Partnership: The historical collaboration between HCA and CHCP, involving program advisory boards, clinical placements, and career placement, reflects a mutual vision for student success and academic quality, which is expected to further professionalize the healthcare industry.
See More
Heritage Insurance Options Trading Volume Surges
- Surge in Options Volume: Heritage Insurance Holdings Inc (HRTG) saw options trading volume reach 4,396 contracts today, representing approximately 439,600 shares, which is about 82.4% of its average daily trading volume of 533,505 shares over the past month, indicating strong market interest in the stock.
- High-Frequency Trading Insights: Notably, the $30 strike call option expiring on July 17, 2026, has seen 4,072 contracts traded today, equating to approximately 407,200 shares of HRTG, suggesting a significant bullish sentiment among investors regarding future price increases.
- Zoom Options Activity: Concurrently, Zoom Communications Inc (ZM) has also shown active options trading, with a volume of 40,748 contracts today, representing around 4.1 million shares, which accounts for 79.7% of its average daily trading volume of 5.1 million shares over the past month, reflecting ongoing market interest.
- Put Option Trading: Among ZM's options, the $90 strike put option expiring on May 22, 2026, has recorded a trading volume of 3,290 contracts, representing approximately 329,000 shares, highlighting investor concerns regarding potential downside risks in its stock price.
See More
HCA Healthcare Completes $3 Billion Bond Offering
- Bond Offering Size: HCA Healthcare completed a $3 billion public offering of senior unsecured notes through its wholly owned subsidiary, HCA Inc., on April 30, 2026, with three tranches maturing in 2031, 2033, and 2036, and interest rates ranging from 4.7% to 5.3%.
- Enhanced Financial Flexibility: The bond issuance aims to diversify long-term funding sources and improve the company's financial flexibility, with all notes fully guaranteed by the parent company, indicating HCA's commitment to future financial stability.
- Analyst Rating Adjustment: On April 28, 2027, Bernstein lowered its price target for HCA Healthcare from $541 to $503 while maintaining a Market Perform rating, reflecting a cautious outlook on the company's long-term EBITDA forecasts, projecting a 5.1% CAGR.
- Operational Risks and Opportunities: Despite risks from slowing state supplemental payments, reduced insurance coverage, and potential bad debt growth, Bernstein's analyst noted that strong operational execution and well-controlled margins could offset these financial challenges, demonstrating HCA's resilience in the market.
See More
